Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 3
2014 4
2015 4
2016 2
2017 1
2018 4
2019 3
2020 5
2021 5
2022 5
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Feasibility study of multimodal imaging for redox status and glucose metabolism in tumor.
Kato K, Yasui H, Sato-Akaba H, Emoto MC, Fujii HG, Kmiec MM, Kuppusamy P, Mizuno Y, Kuge Y, Nagane M, Yamashita T, Inanami O. Kato K, et al. Among authors: nagane m. Free Radic Biol Med. 2024 Jun;218:57-67. doi: 10.1016/j.freeradbiomed.2024.03.028. Epub 2024 Apr 3. Free Radic Biol Med. 2024. PMID: 38574976 Free article.
Chronic oral exposure to low-concentration fumonisin B2 significantly exacerbates the inflammatory responses of allergies in mice via inhibition of IL-10 release by regulatory T cells in gut-associated lymphoid tissue.
Ando M, Yamaguchi H, Morimoto A, Iwashita N, Takagi Y, Nagane M, Yoshinari T, Fukuyama T. Ando M, et al. Among authors: nagane m. Arch Toxicol. 2023 Oct;97(10):2707-2719. doi: 10.1007/s00204-023-03579-0. Epub 2023 Aug 17. Arch Toxicol. 2023. PMID: 37589943
Identification of Methylsulochrin as a Partial Agonist for Aryl Hydrocarbon Receptors and Its Antiviral and Anti-inflammatory Activities.
Nakamura K, Yamasaki M, Ohashi H, Saito S, Ashikawa K, Sato K, Nishioka K, Suzuki Y, Tsurukawa Y, Kanno K, Mosu N, Murakami H, Nagane M, Okada M, Watashi K, Kamisuki S. Nakamura K, et al. Among authors: nagane m. Chem Pharm Bull (Tokyo). 2023 Aug 1;71(8):650-654. doi: 10.1248/cpb.c23-00243. Epub 2023 May 26. Chem Pharm Bull (Tokyo). 2023. PMID: 37245988 Free article.
Ganglioside GM3 deficiency enhances mast cell sensitivity.
Komuro M, Mizugaki H, Nagane M, Morimoto M, Fukuyama T, Ogihara K, Naya Y, Yokomori E, Kaneshima K, Kawakami Y, Kamiie J, Shibata Y, Suzuki M, Shimizu T, Kawashima N, Okamoto M, Ikeda T, Yamashita T. Komuro M, et al. Among authors: nagane m. FEBS J. 2023 Sep;290(17):4268-4280. doi: 10.1111/febs.16806. Epub 2023 May 5. FEBS J. 2023. PMID: 37098812
The novel sustained 3-hydroxybutyrate donor poly-D-3-hydroxybutyric acid prevents inflammatory bowel disease through upregulation of regulatory T-cells.
Suzuki R, Mishima M, Nagane M, Mizugaki H, Suzuki T, Komuro M, Shimizu T, Fukuyama T, Takeda S, Ogata M, Miyamoto T, Aihara N, Kamiie J, Kamisuki S, Yokaryo H, Yamashita T, Satoh T. Suzuki R, et al. Among authors: nagane m. FASEB J. 2023 Jan;37(1):e22708. doi: 10.1096/fj.202200919R. FASEB J. 2023. PMID: 36562544
Cyclic Phthalate Esters as Liver X Receptor Antagonists with Anti-hepatitis C Virus and Anti-severe Acute Respiratory Syndrome Coronavirus 2 Properties.
Saito S, Ohashi H, Nakamura K, Otagaki J, Nishioka K, Nishiuchi K, Nakamura A, Tsurukawa Y, Shibasaki H, Murakami H, Nagane M, Okada M, Kuramochi K, Watashi K, Kamisuki S. Saito S, et al. Among authors: nagane m. Chem Pharm Bull (Tokyo). 2022;70(10):679-683. doi: 10.1248/cpb.c22-00345. Chem Pharm Bull (Tokyo). 2022. PMID: 36184450 Free article.
43 results